A. , S. Hantz, S. Scieux, C. Karras, A. Mazeron et al., Detection of ganciclovir resistance after valacyclovir-prophylaxis in renal transplant recipients with active cytomegalovirus infection, J. Med. Virol, vol.73, pp.566-573, 2004.

A. , S. Revest, M. Veyer, D. Essig, M. Rerolles et al., Maribavir use in practice for cytomegalovirus infection in French transplantation centers, Transplant. Proc, vol.45, pp.1603-1607, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01101099

D. Andouard, M. Mazeron, G. Ligat, A. Couvreux, C. Pouteil-noble et al., Contrasting eect of new HCMV pUL54 mutations on antiviral drug susceptibility: benefits and limits of 3D analysis, Antiviral Res, vol.129, pp.115-119, 2016.

K. K. Biron, R. J. Harvey, S. C. Chamberlain, S. S. Good, A. A. Smith et al., Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action, Antimicrob. Agents Chemother, vol.46, pp.2365-2372, 2002.

N. Biswas and S. K. Weller, A mutation in the C-terminal putative Zn2 + finger motif of UL52 severely aects the biochemical activities of the HSV-1 helicase-primase subcomplex, J. Biol. Chem, vol.274, pp.8068-8076, 1999.

E. M. Borst, G. Hahn, U. H. Koszinowski, and M. Messerle, Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants, J. Virol, vol.73, pp.8320-8329, 1999.

M. S. Chee, A. T. Bankier, S. Beck, R. Bohni, C. M. Brown et al., Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169, Curr. Top. Microbiol. Immunol, vol.154, pp.125-169, 1990.

Z. Cheng, D. Muhlrad, M. K. Lim, R. Parker, and H. Song, Structural and functional insights into the human Upf1 helicase core, EMBO J, vol.26, pp.253-264, 2007.

K. Chono, K. Katsumata, T. Kontani, M. Kobayashi, K. Sudo et al., ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2, J. Antimicrob. Chemother, vol.65, pp.1733-1741, 2010.

L. K. Dropulic and J. I. Cohen, Update on new antivirals under development for the treatment of double-stranded DNA virus infections, Clin. Pharmacol. Ther, vol.88, pp.610-619, 2010.

M. E. Fairman-williams, U. Guenther, J. , and E. , SF1 and SF2 helicases: family matters, Curr. Opin. Struct. Biol, vol.20, pp.313-324, 2010.

H. J. Field and S. Biswas, Antiviral drug resistance and helicase-primase inhibitors of herpes simplex virus, Drug Resist. Updat, vol.14, pp.45-51, 2011.

T. Goldner, G. Hewlett, N. Ettischer, H. Ruebsamen-schae, H. Zimmermann et al., The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase, J. Virol, vol.85, pp.10884-10893, 2011.

K. L. Graves-woodward, J. Gottlieb, M. D. Challberg, and S. K. Weller, Biochemical analyses of mutations in the HSV-1 helicase-primase that alter ATP Ligat et al. Essential Residues of HCMV Helicase-Primase hydrolysis, DNA unwinding, and coupling between hydrolysis and unwinding, J. Biol. Chem, vol.272, pp.4623-4630, 1997.

S. Hantz, F. Garnier-georoy, M. Mazeron, I. Garrigue, P. Merville et al., Drug-resistant cytomegalovirus in transplant recipients: a French cohort study, J. Antimicrob. Chemother, vol.65, pp.2628-2640, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00533269

J. Y. Lee, Y. , and W. , UvrD helicase unwinds DNA one base pair at a time by a two-part power stroke, Cell, vol.127, pp.1349-1360, 2006.

M. Leruez-ville and Y. Ville, Fetal cytomegalovirus infection, Best Pract. Res. Clin. Obstet. Gynaecol, vol.38, pp.97-107, 2017.

W. Li, A. Cowley, M. Uludag, T. Gur, H. Mcwilliam et al., The EMBL-EBI bioinformatics web and programmatic tools framework, Nucleic Acids Res, vol.43, 2015.

G. Ligat, C. Jacquet, S. Chou, A. Couvreux, S. Alain et al., Identification of a short sequence in the HCMV terminase pUL56 essential for interaction with pUL89 subunit, Sci. Rep, vol.7, p.8796, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01985074

P. Lischka, G. Hewlett, T. Wunberg, J. Baumeister, D. Paulsen et al., In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246, Antimicrob. Agents Chemother, vol.54, pp.1290-1297, 2010.

N. S. Lurain and S. Chou, Antiviral drug resistance of human cytomegalovirus, Clin. Microbiol. Rev, vol.23, pp.689-712, 2010.

J. A. Martignetti and B. G. Barrell, Sequence of the HindIII T fragment of human cytomegalovirus, which encodes a DNA helicase, J. Gen. Virol, vol.72, pp.1113-1121, 1991.

T. P. Mcmahon, A. , and D. G. , Interactions between human cytomegalovirus helicase-primase proteins, Virus Res, vol.86, pp.54-54, 2002.

D. P. Melendez, R. , and R. R. , Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus, Infect. Drug Resist, vol.8, pp.269-277, 2015.

M. Nielsen, C. Lundegaard, O. Lund, and T. N. Petersen, CPHmodels3.0-remote homology modeling using structure-guided sequence profiles, Nucleic Acids Res, vol.38, 2010.

E. F. Pai, U. Krengel, G. A. Petsko, R. S. Goody, W. Kabsch et al., Refined crystal structure of the triphosphate conformation of H-ras p21 at 1.35 A resolution: implications for the mechanism of GTP hydrolysis, EMBO J, vol.9, pp.2351-2359, 1990.

G. S. Pari, A. , and D. G. , Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus oriLytdependent DNA replication, J. Virol, vol.67, pp.6979-6988, 1993.

K. Saikrishnan, S. P. Griths, N. Cook, R. Court, and D. B. Wigley, DNA binding to RecD: role of the 1B domain in SF1B helicase activity, EMBO J, vol.27, pp.2222-2229, 2008.

M. Saraste, P. R. Sibbald, and A. Wittinghofer, The P-loop-a common motif in ATP-and GTP-binding proteins, Trends Biochem. Sci, vol.15, pp.430-434, 1990.

M. R. Singleton, M. S. Dillingham, M. Gaudier, S. C. Kowalczykowski, and D. B. Wigley, Crystal structure of RecBCD enzyme reveals a machine for processing DNA breaks, Nature, vol.432, pp.187-193, 2004.

R. M. Story and T. A. Steitz, Structure of the recA protein-ADP complex, Nature, vol.355, pp.374-376, 1992.

S. Sun, K. Kondabagil, P. M. Gentz, M. G. Rossmann, and V. B. Rao, The structure of the ATPase that powers DNA packaging into bacteriophage T4 procapsids, Mol. Cell, vol.25, pp.943-949, 2007.

G. Torres-madriz and H. W. Boucher, Immunocompromised hosts: perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients, Clin. Infect. Dis, vol.47, pp.702-711, 2008.

A. Wald, L. Corey, B. Timmler, A. Magaret, T. Warren et al., , 2014.

, Helicase-primase inhibitor pritelivir for HSV-2 infection, N. Engl. J. Med, vol.370, pp.201-210

J. E. Walker, M. Saraste, M. J. Runswick, and N. J. Gay, Distantly related sequences in the alpha-and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold, EMBO J, vol.1, pp.945-951, 1982.

H. Woon, G. M. Scott, K. L. Yiu, D. H. Miles, and W. D. Rawlinson, Identification of putative functional motifs in viral proteins essential for human cytomegalovirus DNA replication, Virus Genes, vol.37, pp.193-202, 2008.

L. A. Zhu and S. K. Weller, The six conserved helicase motifs of the UL5 gene product, 1992.